• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

    1/26/24 7:58:39 AM ET
    $APTO
    $AREB
    $CISS
    $CVKD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Plastic Products
    Industrials
    Get the next $APTO alert in real time by email

    Shares of Tellurian Inc. (NASDAQ:TELL) shares rose sharply in pre-market trading following a report suggesting the company hired Lazard to explore a possible sale.

    Tellurian shares jumped 16.3% to $0.6050 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Inspire Veterinary Partners, Inc. (NASDAQ:IVP) gained 99.9% to $0.3817 in pre-market trading after jumping over 22% on Thursday.
    • Jaguar Health, Inc. (NASDAQ:JAGX) gained 29.1% to $0.1485 in pre-market trading after gaining around 12% on Thursday.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares jumped 27.2% to $2.22 in pre-market trading following a 15% decline on Thursday.
    • RiskOn International, Inc. (NASDAQ:ROI) gained 21.8% to $0.1481 in pre-market trading after gaining over 9% on Thursday.
    • Vision Marine Technologies Inc. (NASDAQ:VMAR) shares climbed 19.7% to $0.9530 in pre-market trading.
    • Cyngn Inc. (NASDAQ:CYN) surged 16.3% to $0.25 in pre-market trading. Cyngn shares jumped over 17% on Thursday after the company disclosed a strategic shift to Nvidia AI computers that will transform the technology powering its fleet of DriveMod autonomous industrial vehicles.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) shares gained 14.1% to $0.7070 in pre-market trading.
    • Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) shares rose 10.7% to $1.44 in pre-market trading after gaining over 5% on Thursday.
    • InflaRx N.V. (NASDAQ:IFRX) shares gained 9.3% to $1.64 in pre-market trading after falling over 6% on Thursday. InflaRx recently reported topline results from the multiple ascending dose Phase 1 study with C5aR inhibitor INF904.

    Losers

    • Aptose Biosciences Inc. (NASDAQ:APTO) shares dipped 26.7% to $1.40 in pre-market trading after falling 9% on Thursday.
    • Onconetix, Inc. (NASDAQ:ONCO) shares fell 19.5% to $0.2737 in pre-market trading after surging around 130% on Thursday,
    • Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares fell 15.8% to $0.1895 in pre-market trading after the company announced a 1-for-12 reverse stock split.
    • C3is Inc. (NASDAQ:CISS) declined 13.6% to $0.1384 in pre-market trading after gaining over 20% on Thursday. C3is recently announced pricing of its $7 million upsized underwritten public offering.
    • Revelation Biosciences, Inc. (NASDAQ:REVB) fell 12.8% to $9.07 in pre-market trading after declining around 13% on Thursday.
    • Planet Image International Limited (NASDAQ:YIBO) fell 12.2% to $2.45 after dipping 30% on Thursday. Planet Image International priced its initial public offering of 1.25 million ordinary shares at $4 per share.
    • Intel Corporation (NASDAQ:INTC) shares declined 11.4% to $43.89 in pre-market trading. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.
    • American Rebel Holdings, Inc. (NASDAQ:AREB) shares fell 10.2% to $0.3367 in pre-market trading after jumping over 41% on Thursday.
    • KLA Corporation (NASDAQ:KLAC) shares declined 7.5% to $593.50 in pre-market trading after the company reported second-quarter financial results and issued third-quarter guidance.
    • Western Digital Corporation (NASDAQ:WDC) shares dipped 5.2% to $57.20 in pre-market trading. Western Digital reported better-than-expected earnings and sales results for its second quarter.

     

    Now Read This: Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month

    Get the next $APTO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APTO
    $AREB
    $CISS
    $CVKD

    CompanyDatePrice TargetRatingAnalyst
    Western Digital Corporation
    $WDC
    3/31/2026$340.00Mkt Perform → Outperform
    Bernstein
    Intel Corporation
    $INTC
    2/13/2026$45.00Neutral
    DA Davidson
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    Intel Corporation
    $INTC
    1/20/2026$50.00Reduce → Hold
    HSBC Securities
    Intel Corporation
    $INTC
    1/20/2026$65.00Neutral → Buy
    Seaport Research Partners
    KLA Corporation
    $KLAC
    1/15/2026$1697.00Equal-Weight → Overweight
    Morgan Stanley
    KLA Corporation
    $KLAC
    1/15/2026$1550.00Sector Perform
    RBC Capital Mkts
    Intel Corporation
    $INTC
    1/15/2026$50.00Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $APTO
    $AREB
    $CISS
    $CVKD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Western Digital upgraded by Bernstein with a new price target

    Bernstein upgraded Western Digital from Mkt Perform to Outperform and set a new price target of $340.00

    3/31/26 8:07:13 AM ET
    $WDC
    Electronic Components
    Technology

    DA Davidson initiated coverage on Intel with a new price target

    DA Davidson initiated coverage of Intel with a rating of Neutral and set a new price target of $45.00

    2/13/26 8:31:53 AM ET
    $INTC
    Semiconductors
    Technology

    TD Cowen reiterated coverage on Western Digital with a new price target

    TD Cowen reiterated coverage of Western Digital with a rating of Buy and set a new price target of $325.00 from $200.00 previously

    1/30/26 6:45:51 AM ET
    $WDC
    Electronic Components
    Technology

    $APTO
    $AREB
    $CISS
    $CVKD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tan Irving

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    3/24/26 6:17:37 PM ET
    $WDC
    Electronic Components
    Technology

    SEC Form 4 filed by Davis Brian Scott

    4 - WESTERN DIGITAL CORP (0000106040) (Issuer)

    3/24/26 5:53:05 PM ET
    $WDC
    Electronic Components
    Technology

    SEC Form 4 filed by Boyages Steven Constantine

    4 - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Issuer)

    3/20/26 5:00:35 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $APTO
    $AREB
    $CISS
    $CVKD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

    Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k) submission with method comparison, usability, and interference testing NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of its initial clinical Cut-off Study supporting the Company's FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for detection of the opiate codeine. The clinical Cu

    4/2/26 8:30:00 AM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    Intel to Repurchase 49% Equity Interest in Ireland Fab Joint Venture

    Intel Corporation (NASDAQ:INTC) and Apollo (NYSE:APO) today announced a definitive agreement for Intel to repurchase the 49% equity interest in the joint venture related to Intel's Fab 34 in Ireland not held by Intel for $14.2 billion. The agreement reflects Intel's continued business momentum underpinned by the growing and essential role CPUs play in the era of AI, a significantly strengthened balance sheet and the strong partnership between Intel and Apollo. In 2024, Apollo-managed funds and affiliates led an $11.2 billion investment to acquire a 49% equity interest in a joint venture entity related to Fab 34, providing Intel with equity-like capital while preserving balance sheet stren

    4/1/26 9:00:00 AM ET
    $APO
    $INTC
    Investment Managers
    Finance
    Semiconductors
    Technology

    $APTO
    $AREB
    $CISS
    $CVKD
    SEC Filings

    View All

    SEC Form 6-K filed by Vision Marine Technologies Inc.

    6-K - Vision Marine Technologies Inc. (0001813783) (Filer)

    4/3/26 4:30:09 PM ET
    $VMAR
    Marine Transportation
    Industrials

    SEC Form S-1 filed by American Rebel Holdings Inc.

    S-1 - AMERICAN REBEL HOLDINGS INC (0001648087) (Filer)

    4/3/26 4:06:38 PM ET
    $AREB
    Plastic Products
    Industrials

    Intel Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - INTEL CORP (0000050863) (Filer)

    4/3/26 12:50:37 PM ET
    $INTC
    Semiconductors
    Technology

    $APTO
    $AREB
    $CISS
    $CVKD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO Zinsner David bought $249,985 worth of shares (5,882 units at $42.50), increasing direct ownership by 2% to 247,392 units (SEC Form 4)

    4 - INTEL CORP (0000050863) (Issuer)

    1/27/26 4:28:29 PM ET
    $INTC
    Semiconductors
    Technology

    Large owner Hrt Financial Lp bought $2,776,489 worth of Class A Shares (230,223 units at $12.06) and sold $2,417,788 worth of Class A Shares (181,652 units at $13.31) (SEC Form 4)

    4 - AMERICAN REBEL HOLDINGS INC (0001648087) (Issuer)

    4/9/25 11:26:05 AM ET
    $AREB
    Plastic Products
    Industrials

    Chair, President & CEO Rice William G. bought $20,000 worth of shares (100,000 units at $0.20), increasing direct ownership by 19% to 613,252 units (SEC Form 4)

    4 - Aptose Biosciences Inc. (0000882361) (Issuer)

    11/26/24 6:56:32 PM ET
    $APTO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APTO
    $AREB
    $CISS
    $CVKD
    Leadership Updates

    Live Leadership Updates

    View All

    Intel Appoints Aparna Bawa as Executive Vice President and Chief Legal & People Officer

    Intel Corporation today announced the appointment of Aparna Bawa as EVP, chief legal & people officer. Bawa will report directly to CEO Lip-Bu Tan and will lead Intel's global legal, ethics, compliance, people, and culture organizations as the company accelerates its transformation and execution agenda. "The role of legal and people leadership has never been more critical as Intel drives cultural transformation with discipline, speed, and integrity," said Intel CEO Lip-Bu Tan. "Aparna brings a rare combination of operational rigor, business judgment, and people-first leadership. Her experience helping scale global technology companies through periods of significant change will be invaluab

    4/2/26 4:05:00 PM ET
    $INTC
    Semiconductors
    Technology

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Cyngn Partners with Chandler Automation, Expands into Agriculture

    MOUNTAIN VIEW, Calif., Dec. 23, 2025 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced that Chandler Automation has joined its dealer network and will begin offering Cyngn's autonomous DriveMod Tugger to food processors and packers in the agriculture sector. Chandler Automation is a full-service partner in factory automation, specializing in optical sorting, inspection, robotic palletizing, and custom processing machinery. Known for delivering tailored, high-performance systems, Chandler empowers food processors to reduce labor costs, boost efficiency, and stay competitive wi

    12/23/25 7:00:00 AM ET
    $CYN
    EDP Services
    Technology

    $APTO
    $AREB
    $CISS
    $CVKD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Intelligent Bio Solutions Inc.

    SC 13G/A - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    11/14/24 7:16:17 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by TC BioPharm (Holdings) plc

    SC 13G/A - TC BioPharm (Holdings) plc (0001872812) (Subject)

    11/14/24 4:41:42 PM ET
    $TCBP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Intelligent Bio Solutions Inc.

    SC 13G - INTELLIGENT BIO SOLUTIONS INC. (0001725430) (Subject)

    11/14/24 4:31:30 PM ET
    $INBS
    Medical/Dental Instruments
    Health Care

    $APTO
    $AREB
    $CISS
    $CVKD
    Financials

    Live finance-specific insights

    View All

    Intel to Report First-Quarter 2026 Financial Results

    Intel Corporation today announced that it will report first-quarter financial results on Thursday, April 23, 2026, promptly after close of market. Intel will then hold an earnings conference call at 2 p.m. PT that day to discuss the results. A live public webcast of the earnings conference call can be accessed on Intel's Investor Relations website at intc.com. Associated materials and webcast replay will also be available on the site. About Intel Intel (NASDAQ:INTC) designs and manufactures advanced semiconductors that connect and power the modern world. Every day, our engineers create new technologies that enhance and shape the future of computing to enable new possibilities for ever

    3/31/26 5:02:00 PM ET
    $INTC
    Semiconductors
    Technology

    Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

    PONTE VEDRA, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions, today reported its financial results for the fourth quarter and full year ended December 31, 2025, and provided a corporate update highlighting recent progress across its CAD-1005 program for HIT and broader 12-LOX inhibitor platform. The update reflects continued progress for CAD-1005, Cadrenal's first-in-class 12-LOX inhibitor for suspected heparin-induced thrombocytopenia (HIT), including completion of its End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administra

    3/31/26 8:45:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones

    Promising Phase 2a data announced for izicopan, underscoring its potential as a meaningfully differentiated, effective and safe oral inhibitor of C5aRSubstantial progress made toward Phase 2b readiness for izicopan in hidradenitis suppurativa (HS)InflaRx actively reviewing and considering additional development in ANCA‑associated vasculitis (AAV)To broaden izicopan signal-finding activities and expedite proof-of-concept studies into additional indications in inflammation and immunology (I&I), InflaRx intends to conduct a pharmacokinetic (PK) bridging study in China this yearActive dialog with potential collaborators to expedite the Company's total pipeline development goals continuesInflaRx

    3/19/26 7:30:00 AM ET
    $IFRX
    Biotechnology: Pharmaceutical Preparations
    Health Care